Skip to Content
CancersCancers
  • Review
  • Open Access

1 July 2020

16 Pages

Reactive Oxygen Species and Antitumor Immunity—From Surveillance to Evasion

,
,
and
1
Laboratory of Advanced Translational Research, Veneto Institute of Oncology IOV-IRCCS, 35128 Padua, Italy
2
General Surgery Unit, Azienda Ospedaliera di Padova, 35128 Padua, Italy
3
Department of Molecular Medicine DMM, University of Padua, 35121 Padua, Italy
*
Author to whom correspondence should be addressed.

Abstract

The immune system is a crucial regulator of tumor biology with the capacity to support or inhibit cancer development, growth, invasion and metastasis. Emerging evidence show that reactive oxygen species (ROS) are not only mediators of oxidative stress but also players of immune regulation in tumor development. This review intends to discuss the mechanism by which ROS can affect the anti-tumor immune response, with particular emphasis on their role on cancer antigenicity, immunogenicity and shaping of the tumor immune microenvironment. Given the complex role that ROS play in the dynamics of cancer-immune cell interaction, further investigation is needed for the development of effective strategies combining ROS manipulation and immunotherapies for cancer treatment.

Article Metrics

Citations

Article Access Statistics

Multiple requests from the same IP address are counted as one view.